SavedAdd your journal

Journals / Southern Clinics of Istanbul Eurasia / 2017 / Cilt: 28 - Sayı: 2

Evaluation of the Relationship Between Insulin Resistance and Selenoprotein P in Patients with Polycystic Ovary Syndrome

Ayşenur ÖZDERYA
İbrahim YILMAZ
Şevin DEMİR
Şule TEMİZKAN
Mehmet SARGIN
Mehmet ALİUSTAOĞLU
Kadriye AYDIN
Pages
99–104
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, the correlation of SeP with WC and testosterone in PCOS suggests a possible metabolic relationship

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Polycystic ovary syndrome (PCOS) is the most frequently seen disorder in women of childbearing age, and is characterized by insulin resistance (IR).
📊
Key Findings & Data:The aim of the present study was to determine SeP levels in PCOS and to investigate its relationship to IR.Methods: A total of 27 patients and 27 age- and body mass index (BMI)-matched healthy controls were included in the study.
💡
Conclusion & Impact:However, the correlation of SeP with WC and testosterone in PCOS suggests a possible metabolic relationship
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Polycystic ovary syndrome (PCOS) is the most frequently seen disorder in women of childbearing age, and is characterized by insulin resistance (IR). Selenoprotein P (SeP) is a hepatokine associated with IR. The aim of the present study was to determine SeP levels in PCOS and to investigate its relationship to IR.Methods: A total of 27 patients and 27 age- and body mass index (BMI)-matched healthy controls were included in the study. Demographic data, anthropometric measurements, and biochemical parameters were evaluated. IR and free androgen index were calculated. Analysis of the correlation of biochemical and anthropometric parameters with SeP was performed. Results: There was a significant difference in the mean fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR) between patients and controls (both p<0.05), while the SeP level was similar (1.05±0.7ng/mL, 1.61±1.9ng/mL, respectively; p=0.7). There was no correlation between SeP and HOMA-IR in either group. There was a negative correlation between SeP and waist circumference (WC) in the PCOS group (p=0.03; r=-0.485), but not in the control group. In the control group, there was a negative correlation between SeP and BMI and fat percentage (r=-0.506, p=0.007; r=-0.643, p=0.024, respectively), but not in the PCOS group. In addition, there was a significant positive correlation between testosterone and SeP in the patients (r=0.456; p=0.017). Conclusion: The SeP level was similar in patients and controls, and there was no correlation between SeP and IR in the PCOS group. However, the correlation of SeP with WC and testosterone in PCOS suggests a possible metabolic relationship

🔖

Cite This Article

ÖZDERYA, A., YILMAZ, İ., DEMİR, Ş., TEMİZKAN, Ş., SARGIN, M., ALİUSTAOĞLU, M., AYDIN, K. (2017). Evaluation of the Relationship Between Insulin Resistance and Selenoprotein P in Patients with Polycystic Ovary Syndrome. Southern Clinics of Istanbul Eurasia, Cilt: 28 - Sayı: 2, 99–104. https://ajindex.com/articles/314137

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Slowey MJ. Polycystic ovary syndrome: new perspective on an old problem. South Med J 2001;94:190–6
  2. Nestler JE. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin Reprod Endocrinol 1997;15:111–22
  3. Ahles BL. Toward a new approach: primary and preventive care of the woman with polycystic ovarian syndrome. Prim Care Update Ob Gyns 2000;7:275–8
  4. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774–800
  5. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980;50:113–6
  6. Méplan C, Crosley LK, Nicol F, Beckett GJ, Howie AF, Hill KE, et al. Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J 2007;21:3063–74
  7. Yang X, Jansson PA, Nagaev I, Jack MM, Carvalho E, Sunnerhagen KS, et al. Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun 2004;317:1045–51
  8. Zhang Y, Chen X. Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation. Am J Physiol Endocrinol Metab 2011;300:E77–85
  9. Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 2011;96:E1325–9
  10. Misu H, Ishikura K, Kurita S, Takeshita Y, Ota T, Saito Y, et al. Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PLoS One 2012;7:e34952
  11. Nordio M. A novel treatment for subclinical hyperthyroidism: a pilot study on the beneficial effects of l-carnitine and selenium. Eur Rev Med Pharmacol Sci 2017;21:2268–73
  12. Long M, Yang S, Wang Y, Li P, Zhang Y, Dong S, et al. The Protective Effect of Selenium on Chronic Zearalenone-Induced Reproductive System Damage in Male Mice. Molecules 2016;21: E1687
  13. Lipinski B. Sodium Selenite as an Anticancer Agent. Anticancer Agents Med Chem 2017;17:658–61
  14. Ezaki O. The insulin-like effects of selenate in rat adipocytes. J Biol Chem 1990;265:1124–8
  15. Mueller AS, Pallauf J. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo